-+ 0.00%
-+ 0.00%
-+ 0.00%

LANTERN PHARMA INC - PHASE 2 FOCUSES ON MULTI-DISEASE EXPANSION AND REVENUE ACCELERATION

Reuters·01/12/2026 14:06:44

Please log in to view news